# A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinoma

> clinical trial · VERIFIED · 2026-07-09

Status: NOT_YET_RECRUITING · Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Condition: Hepatocellular Carcinoma

- Company: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Sector: Hepatocellular Carcinoma
- Primary source: https://clinicaltrials.gov/study/NCT07691762

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.